Eloxx Pharmaceuticals IncELOX
Price$15.71

Financial Snapshot

Revenue, profitability, returns, debt, and capital allocation

Revenue $0
Net Income -$6M

Margins

Current

Dividend

No dividend

Segment Performance

SegmentRevenueYoYOutlook
Life Science$0
View details

Advancing lead investigational drug candidates, including exaluren (ELX-02) for Alport syndrome and ZKN-013 for rare skin diseases.

All values are periodic snapshots, not live quotes. Source dates are shown for reference.

Filing Detail Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up
AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.